Literature DB >> 17963171

Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome.

T Mandl1, O Ekberg, P Wollmer, R Manthorpe, L T H Jacobsson.   

Abstract

OBJECTIVES: To assess the prevalence of pharyngeal and oesophageal symptoms and dysmotility in patients with primary Sjögren's syndrome (pSS) and relate these to autonomic nervous function.
METHODS: Twenty consecutive pSS patients, according to the American-European Consensus Criteria (AECC), and 30 age- and sex-matched controls from the Swedish general population registry were studied. All subjects completed a pharyngeal and oesophageal symptoms questionnaire and were examined by pharyngeal and oesophageal video radiography. In addition, the pSS patients were examined by two different autonomic nervous function tests, the deep breathing test [calculating the expiration/inspiration (E/I) ratio] and the finger skin blood flow test [the vasoconstriction (VAC) index].
RESULTS: pSS patients experienced significantly more dysphagia compared with controls (65% vs. 3%; p<0.001). Pharyngeal (45% vs. 7%; p<0.01), oesophageal (80% vs. 7%; p<0.001) and gastro-oesophageal reflux symptoms (60% vs. 23%; p<0.01) were also more prevalent in pSS patients compared with controls while pharyngeal (15% vs. 17%; p = NS) and oesophageal dysmotility (40% vs. 30%; p = NS) were not. Dysphagia was not associated with dysmotility but was found to be associated with a decreased E/I ratio [-1.05 (-1.51 to -0.40) in patients with dysphagia vs. -0.21 (-0.39 to 0.65) in patients without dysphagia; p<0.01].
CONCLUSION: Subjective swallowing difficulties were more common in pSS patients than in controls while objective signs of pharyngeal and oesophageal dysmotility were not. Dysphagia in pSS patients does not seem to be related to video radiographical signs of dysmotility but may be related to an impaired parasympathetic function.

Entities:  

Mesh:

Year:  2007        PMID: 17963171     DOI: 10.1080/03009740701607638

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  11 in total

1.  Swallowing Disorders in Sjögren's Syndrome: Prevalence, Risk Factors, and Effects on Quality of Life.

Authors:  Jenny L Pierce; Kristine Tanner; Ray M Merrill; Karla L Miller; Katherine A Kendall; Nelson Roy
Journal:  Dysphagia       Date:  2015-10-19       Impact factor: 3.438

Review 2.  Pathogenesis of Sjögren's syndrome.

Authors:  Nikolay P Nikolov; Gabor G Illei
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 3.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

4.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary Sjögren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian society of rheumatology (hepatic, gastrointestinal and pancreatic).

Authors:  Virginia Fernandes Moça Trevisani; Aysa César Pinheiro; Sonia Cristina de Magalhães Souza Fialho; Marilena Leal Mesquita Silvestre Fernandes; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D 'Agostino Gennari; Karina Gatz Capobianco; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; Aline Pereira da Rocha; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-10-10

Review 5.  Esophageal Motility Disorders: Current Approach to Diagnostics and Therapeutics.

Authors:  Dhyanesh A Patel; Rena Yadlapati; Michael F Vaezi
Journal:  Gastroenterology       Date:  2022-02-25       Impact factor: 33.883

6.  Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).

Authors:  Mariette Bengtsson; Oskar Hammar; Thomas Mandl; Bodil Ohlsson
Journal:  BMC Gastroenterol       Date:  2011-11-10       Impact factor: 3.067

7.  Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.

Authors:  Monisha Billings; Bruce A Dye; Timothy Iafolla; Alan N Baer; Margaret Grisius; Ilias Alevizos
Journal:  EBioMedicine       Date:  2016-09-09       Impact factor: 8.143

8.  Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.

Authors:  Thomas Mandl; Jan Marsal; Peter Olsson; Bodil Ohlsson; Kristofer Andréasson
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

9.  The Frequency of Primary Sjogren's Syndrome and Fibromyalgia in Irritable Bowel Syndrome.

Authors:  Funda Erbasan; Yesim Cekin; Deniz Turgut Coban; Ugur Karasu; Dinc Suren; Ayhan H Cekin
Journal:  Pak J Med Sci       Date:  2017 Jan-Feb       Impact factor: 1.088

10.  Dietary Intake, Body Composition, and Oral Health Parameters among Female Patients with Primary Sjögren's Syndrome.

Authors:  Marianne B Nesvold; Janicke L Jensen; Lene H Hove; Preet B Singh; Alix Young; Øyvind Palm; Lene Frost Andersen; Monica H Carlsen; Per Ole Iversen
Journal:  Nutrients       Date:  2018-07-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.